1.
Quaglia FM, Rigolin GM, Saccenti E, Negrini M, Volta E, Dabusti M, Ciccone M, Urso A, Laudisi M, Cuneo A. Response to ibrutinib of a refractory IgA lymphoplasmacytic lymphoma carrying the MYD88 L265P gene mutation. Mediterr J Hematol Infect Dis [Internet]. 2019 Aug. 29 [cited 2022 Sep. 28];11(1):e2019057. Available from: https://mjhid.org/index.php/mjhid/article/view/2019.057